*ST嘉信(300071.SZ):持股5%以上的劉偉擬被動減持1380萬股
格隆匯6月16日丨*ST嘉信(300071.SZ)公佈,公司今日收到呂凡華的吿知函,由於公司持股5%以上股東劉偉與呂凡華借貸合同糾紛,法院對劉偉持有的公司股票決定予以司法處置強制變現,由華泰證券協助執行,華泰證券擬通過大宗交易方式對劉偉持有的部分公司股票進行處置,擬減持數量1380萬股,佔公司總股本比例2.06%。
截止公吿披露日,劉偉持有公司股份8520.6619萬股,佔公司總股本的12.69%。劉偉共質押其持有的公司股份8062.8138萬股,佔公司總股本的12.01%,全部為無限售條件流通股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.